Keisuke Ishizawa Selected Research

nitrosonifedipine

1/2018	Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation.
1/2017	Topical application of nitrosonifedipine, a novel radical scavenger, ameliorates ischemic skin flap necrosis in a mouse model.
1/2014	Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects.
1/2013	Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keisuke Ishizawa Research Topics

Disease

22	Neoplasms (Cancer) 02/2022 - 04/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 10/2005
10	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2019
10	Hypertension (High Blood Pressure) 01/2021 - 08/2005
9	Hypoxia (Hypoxemia) 01/2017 - 01/2011
5	Chronic Renal Insufficiency 01/2022 - 01/2009
5	Atherosclerosis 09/2020 - 03/2006
5	Inflammation (Inflammations) 01/2020 - 01/2012
5	Vascular Remodeling 12/2019 - 02/2010
5	Ischemia 05/2019 - 10/2012
4	Fibrosis (Cirrhosis) 08/2022 - 01/2014
4	Peripheral Nervous System Diseases (PNS Diseases) 04/2022 - 01/2017
4	Breast Neoplasms (Breast Cancer) 02/2022 - 11/2019
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 04/2015
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2019
4	Obesity 01/2020 - 11/2011
4	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2015
4	Anemia 01/2020 - 01/2017
3	Malignant Mesothelioma 01/2022 - 01/2015
3	Body Weight (Weight, Body) 01/2021 - 02/2010
3	Aortic Aneurysm (Aneurysm, Aortic) 09/2020 - 01/2018
3	Brain Ischemia (Cerebral Ischemia) 03/2020 - 06/2018
3	Heart Arrest (Cardiac Arrest) 01/2019 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2015 - 11/2011
3	Proteinuria 01/2014 - 11/2008
2	Stomatitis 08/2022 - 01/2016
2	Dysgeusia (Parageusia) 01/2022 - 01/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2015
2	Exanthema (Rash) 01/2022 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2022 - 07/2006
2	Seizures (Absence Seizure) 07/2021 - 07/2020
2	Epilepsy (Aura) 07/2021 - 07/2020
2	Acute Coronary Syndrome 01/2021 - 01/2020
2	Nausea 01/2021 - 01/2021
2	Vomiting 01/2021 - 01/2021
2	Hemorrhage 01/2021 - 01/2021
2	Glomerulonephritis 11/2020 - 02/2010
2	Aortic Dissection 09/2020 - 01/2019
2	Sepsis (Septicemia) 08/2020 - 01/2018
2	Critical Illness (Critically Ill) 08/2020 - 01/2017
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020 - 01/2018
2	Insulin Resistance 01/2020 - 08/2005
2	Neutropenia 11/2019 - 03/2019
2	Atrophy 01/2019 - 05/2016
2	Glioma (Gliomas) 10/2015 - 03/2012

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 08/2022 - 09/2006
10	IronIBA 01/2020 - 01/2012
9	Angiotensin IIIBA 09/2020 - 08/2005
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2011
5	Messenger RNA (mRNA)IBA 08/2022 - 03/2013
4	CytokinesIBA 08/2022 - 02/2010
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2020 - 02/2010
4	nitrosonifedipineIBA 01/2018 - 01/2013
4	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2010 - 05/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 01/2019
3	Cyclin-Dependent Kinase 4IBA 01/2022 - 09/2006
3	Pemetrexed (MTA)FDA Link 01/2022 - 01/2015
3	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2019
3	Therapeutic UsesIBA 01/2021 - 01/2019
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2005
3	FlavonoidsIBA 09/2020 - 02/2009
3	QuercetinIBA 09/2020 - 02/2009
3	AminopropionitrileIBA 09/2020 - 01/2018
3	Hydroxyl RadicalIBA 03/2020 - 06/2018
3	Superoxides (Superoxide)IBA 01/2019 - 01/2011
3	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 02/2009
3	Insulin (Novolin)FDA Link 11/2011 - 08/2005
2	Simvastatin (Zocor)FDA LinkGeneric 10/2022 - 04/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2022 - 01/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 02/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2015
2	Febuxostat FDA Link 01/2022 - 12/2019
2	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 01/2016
2	Pentylenetetrazole (Metrazol)IBA 07/2021 - 07/2020
2	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2020
2	Prasugrel Hydrochloride FDA Link 01/2021 - 01/2020
2	Vancomycin FDA LinkGeneric 08/2020 - 12/2019
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2020 - 11/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 01/2016
2	NitratesIBA 05/2019 - 02/2010
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2019 - 01/2019
2	UbiquitinIBA 01/2019 - 05/2016
2	Ligases (Synthetase)IBA 01/2019 - 05/2016
2	Antipsychotic Agents (Antipsychotics)IBA 12/2018 - 01/2017
2	Ferritins (Ferritin)IBA 01/2018 - 08/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 07/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2015 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 03/2012
2	AntibodiesIBA 10/2015 - 01/2005
2	Oxygen (Dioxygen)IBA 04/2015 - 01/2015

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 08/2022 - 06/2014
5	Therapeutics 01/2022 - 01/2019
4	Oral Administration 08/2022 - 05/2006
3	Critical Care (Surgical Intensive Care) 01/2018 - 01/2017
2	Percutaneous Coronary Intervention 01/2021 - 01/2020
2	Kampo Medicine (Kampo) 01/2018 - 01/2017
2	Lasers (Laser) 11/2015 - 10/2012